Chair and Roy and Eulalia Swank Family Research Professor
Neurology
Dr. Dennis N. Bourdette, MD
|
|
Give Review
Dr. Dennis N. Bourdette practices Neurology. He researched medicine at University of California Davis School of Medicine. University of California Davis School of Medicine is ranked 43/19 in Research/PrimaryCare. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Dennis Bourdette is a published doctor. He has 98 papers published. The most current publication "Immunopathology of Japanese macaque encephalomyelitis is similar to multiple sclerosis." Doctor Dennis N. Bourdette, MD accepts all Medicare patients.
Publications
- Immunopathology of Japanese macaque encephalomyelitis is similar to Multiple sclerosis.
- Polyphenon E, non-futile at neuroprotection in multiple sclerosis but unpredictably hepatoToxic: Phase I single group and phase II randomized placebo-controlled studies.
- Cognitive Impairment and Community Integration Outcomes in Individuals Living with Multiple Sclerosis.
- The use of flow cytometry to assess a novel drug efficacy in Multiple sclerosis.
- Does interferon Beta-1a impact pure-tone hearing sensitivity among individuals with Multiple sclerosis?
- Remyelination and Multiple sclerosis: therapeutic approaches and challenges.
- Venous angioplasty for "CCSVI" in Multiple sclerosis: Ending a therapeutic misadventure.
- Alemtuzumab and Multiple sclerosis: Is it safe?
- Improving the Patient-Reported Outcome Experience for Participants and PI's: Feasibility and Validity of PROMIS.
- Summary of evidence-based guideline: Complementary and alternative medicine in Multiple sclerosis: Report of the Guideline Development Subcommittee of the American Aca...
- Body-worn sensors capture variability, but not decline, of Gait and balance measures in multiple sclerosis over 18 months.
- New treatments for Multiple sclerosis: at what long-term risk?
- Perceived Stress in Multiple Sclerosis: The Potential Role of Mindfulness in Health and Well-Being.
- Response to comment on letter for Prevalence of Brain magnetic resonance imaging meeting Barkhof and Mc Donald criteria for dissemination in space among headache patie...
- Tumefactive Multiple sclerosis and fingolimod: Immunotherapies and unintended consequences.
- A Randomized Placebo-Controlled Pilot Trial of Omega-3 Fatty Acids and Alpha Lipoic Acid in Alzheimer's Disease.
- Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects.
- People with Multiple Sclerosis use many fall prevention strategies but still fall frequently.
- Prevalence of Brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients.
- Anti-NMDA receptor encephalitis with paroxysmal sympathetic hyperactivity: an under-recognized association?
- Treat patients with radiologically isolated syndrome when the MRI Brain scan shows dissemination in time: No.
- Focal Increases of Axoplasmic Ca2+, Aggregation of Sodium-Calcium Exchanger, N-type Ca2+ Channel, and Actin Define the Sites of Spheroids in Axons Undergoing Oxidative...
- Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
- New Disease-Modifying Therapies and New Challenges for MS.
- Recombinant T-Cell Receptor Ligand (RTL) for Treatment of Multiple Sclerosis: A Double-Blind, Placebo-Controlled, Phase 1, Dose-Escalation Study.
- Cognitive Impairment and MS: Searching for Effective Therapies.
- Japanese macaque encephalomyelitis: A spontaneous Multiple sclerosis-like disease in a nonhuman primate.
- Lipoic acid stimulates cAMP production via G protein-coupled receptor-dependent and -independent mechanisms.
- Immunomodulatory therapies in neurologic critical care.
- Lipoic acid attenuates inflammation via cAMP and protein kinase A signaling.
- Audiometric hearing status of individuals with and without Multiple sclerosis.
- Lipoic acid downmodulates CD4 from human T lymphocytes by dissociation of p56(Lck).
- Exploring educational needs of Multiple sclerosis care providers: Results of a care-provider survey.
- Correlations of Perceived Deficits Questionnaire of Multiple Sclerosis Quality of Life Inventory with Beck Depression Inventory and neuropsychological tests.
- Cognition and fatigue in multiple sclerosis: Potential effects of medications with central Nervous system activity.
- Some effects of Multiple sclerosis on speech perception in noise: Preliminary findings.
- Alpha lipoic acid inhibits human T-cell migration: implications for Multiple sclerosis.
- T-cell hybridoma specific for myelin oligodendrocyte glycoprotein-35-55 peptide produced from HLA-DRB1*1501-transgenic mice.
- FK506 and a nonimmunosuppressant derivative reduce axonal and myelin damage in experimental autoimmune encephalomyelitis: neuroimmunophilin ligand-mediated neuroprotec...
- Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
- Specificity of regulatory CD4+CD25+ T cells for self-T cell receptor determinants.
- CD4 T-cell epitopes of human alpha B-crystallin.
- Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity.
- CNS gene expression pattern associated with spontaneous experimental autoimmune encephalomyelitis.
- Production, characterization, and immunogenicity of a soluble rat single chain T cell receptor specific for an encephalitogenic peptide.
- Chronic fatigue in a population-based study of Gulf War veterans.
- Falls in people with Multiple sclerosis compared with falls in healthy controls.
- Fatigue is associated with poor sleep in people with Multiple sclerosis and cognitive impairment.
- Predicting falls in people with Multiple sclerosis: fall history is as accurate as more complex measures.
- Mitochondrial dysfunction and neurodegeneration in Multiple sclerosis.
- Depression is a treatable cause of suffering among Multiple sclerosis patients and can result in suicide.
- Cognitive dysfunction in Multiple sclerosis: natural history, pathophysiology and management.
- Neuroregenerative and neuroprotective actions of neuroimmunophilin compounds in traumatic and Inflammatory neuropathies.
- Epitope spreading is not required for relapses in experimental autoimmune encephalomyelitis.
- Nonmyelin-specific T cells accelerate development of central Nervous system APC and increase susceptibility to experimental autoimmune encephalomyelitis.
- Complementary and alternative medicine in Multiple sclerosis: survey of licensed naturopaths.
- Centella asiatica accelerates nerve regeneration upon oral administration and contains Multiple active fractions increasing neurite elongation in-vitro.
- Decreased FOXP3 levels in Multiple sclerosis patients.
- Cyclophilin D inactivation protects axons in experimental autoimmune encephalomyelitis, an animal model of Multiple sclerosis.
- A randomized pilot study of naturopathic medicine in Multiple sclerosis.
- Complementary and alternative medicine: is there a role in Multiple sclerosis?
- Frequency-modulation (FM) technology as a method for improving speech perception in noise for individuals with Multiple sclerosis.
- Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with Multiple sclerosis.
- Axonal degeneration in Multiple sclerosis: the mitochondrial hypothesis.
- Alemtuzumab versus interferon beta-1a in early Multiple sclerosis.
- The radiologically isolated syndrome: is it very early Multiple sclerosis?
- Imbalance in Multiple sclerosis: a result of slowed spinal somatosensory conduction.
- Recent developments in Multiple sclerosis therapeutics.
- Immunotherapy and Multiple sclerosis: The devil is in the details.
- Complementary and alternative medicine for the treatment of Multiple sclerosis.
- Genetic inactivation of the p66 isoform of ShcA is neuroprotective in a murine model of Multiple sclerosis.
- Inflammatory neurological disease in patients treated with tumor necrosis factor alpha inhibitors.
- The radiologically isolated syndrome revisited: when is it presymptomatic Multiple sclerosis?
- Activation of the mitochondrial permeability transition pore modulates Ca2+ responses to physiological stimuli in adult neurons.
- Lipoic acid decreases inflammation and confers neuroprotection in experimental autoimmune optic neuritis.
- Novel method for measurement of fatigue in Multiple sclerosis: Real-Time Digital Fatigue Score.
- Disability progression in a clinical trial of relapsing-remitting Multiple sclerosis: eight-year follow-up.
- Oral disease-modifying therapies for Multiple sclerosis: are we there yet?
- New oral disease-modifying therapies for Multiple sclerosis.
- Interruption of natalizumab therapy for Multiple sclerosis: what are the risks?
- Falls requiring medical attention among veterans with Multiple sclerosis: a cohort study.
- The radiologically isolated Syndrome: look (again) before you treat.
- Mitochondrial calcium and its regulation in neurodegeneration induced by oxidative stress.
- Pharmacokinetic study of lipoic acid in Multiple sclerosis: comparing mice and human pharmacokinetic parameters.
- NMDA receptor encephalitis mimicking seronegative neuromyelitis optica.
- Clinical trial of a formal group fatigue program in Multiple sclerosis.
- Lipoic acid stimulates cAMP production via the EP2 and EP4 prostanoid receptors and inhibits IFN gamma synthesis and cellular cytoToxicity in NK cells.
- Lipoic acid: a novel therapeutic approach for multiple sclerosis and other Chronic inflammatory diseases of the CNS.
- Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE.
- Lipoic acid stimulates cAMP production in T lymphocytes and NK cells.
- Lipopolysaccharide pretreatment modulates the Disease course in experimental autoimmune encephalomyelitis.
- Lipoic acid inhibits expression of ICAM-1 and VCAM-1 by CNS endothelial cells and T cell migration into the spinal cord in experimental autoimmune encephalomyelitis.
- A highly immunogenic trivalent T cell receptor peptide vaccine for Multiple sclerosis.
- Therapeutic vaccination with a trivalent T-cell receptor (TCR) peptide vaccine restores deficient FoxP3 expression and TCR recognition in subjects with Multiple sclero...
- Dysregulation of the hypothalamic-pituitary-gonadal axis in experimental autoimmune encephalomyelitis and Multiple sclerosis.
- Alpha lipoic acid inhibits T cell migration into the spinal cord and suppresses and treats experimental autoimmune encephalomyelitis.
- Myelin basic protein-specific T lymphocytes induce Chronic relapsing experimental autoimmune encephalomyelitis in lymphocyte-deficient (SCID) mice.
Schools
University Of California Davis School Of Medicine
Santa Clara Valley Med Center
Oregon Health Science University
Va Med Center
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Ataxia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Aneurysm
- Chronic Inflammatory Demyelinating Polyneuritis
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Oregon Health & Science University -
Santa Clara Valley Medical Center -
University of California Davis School of Medicine
Drug Facts
| NPI NUMBER | 1104831619 | |
| NPPES Provider LastName | BOURDETTE | |
| NPPES Provider FirstName | DENNIS | |
| NPPES Provider ZIPCode | 972393011 | |
| NPPES Provider State | OR | |
| Specialty Description | Neurology | |
| Total Claim Count | 121.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1104831619 |
| Last Name Of The Provider | BOURDETTE |
| First Name Of The Provider | DENNIS |
| View All |
Similar Doctors
|
|
Dr. Chad C. Hagen, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine M. Ellison, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Brent A. Burroughs, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin C. Salinsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ghazaleh Jafari, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James J. Cereghino, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bethany M. McClenathan, MD |
|
|
Dr. Meredith C. Frederick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tammy Pham, MD |